Small extracellular vesicles called exosomes affect multiple autocrine and paracrine cellular phenotypes. Understanding the function of exosomes requires a variety of tools, including live imaging. Our previous live-cell reporter, pHluorin-CD63, allows dynamic subcellular monitoring of exosome secretion in migrating and spreading cells. However, dim fluorescence and the inability to make stably-expressing cell lines limit its use. We incorporated a stabilizing mutation in the pHluorin moiety, M153R, which now exhibits higher, stable expression in cells and superior monitoring of exosome secretion. Using this improved construct, we visualize secreted exosomes in 3D culture and in vivo and identify a role for exosomes in promoting leader–follower behavior in 2D and 3D migration. Incorporating an additional non-pH-sensitive red fluorescent tag allows visualization of the exosome lifecycle, including multivesicular body (MVB) trafficking, MVB fusion, exosome uptake and endosome acidification. This reporter will be a useful tool for understanding both autocrine and paracrine roles of exosomes.
Directional cell motility toward a chemical gradient, chemotaxis, is critical during inflammation, embryogenesis, and cancer metastasis. In this issue, Kriebel et al. (2018. J. Cell Biol.https://doi.org/10.1083/jcb.201710170) demonstrate that the key cAMP chemoattractant for Dictyostelium discoideum amoebas is synthesized within and released from extracellular vesicles to promote chemotaxis.
22 September 2025 in Journal of Extracellular Vesicles
Extracellular vesicles (EVs) represent a cytokine‐independent pathway though which skeletal muscle (SkM) cells influence the fate of neighbouring cells, thereby regulating SkM metabolic homeostasis and regeneration. Although SkM‐EVs are increasingly being explored as a therapeutic strategy to enhance muscle regeneration or to induce the myogenic differentiation of induced pluripotent stem cells (iPSCs), the mechanisms governing their release from muscle cells remain poorly described. Moreover, because muscle regeneration involves a tightly regulated inflammatory response it also important to determine how inflammation alters SkM‐EV cargo and function in order to design more effective EV‐based therapies. To address this knowledge gap, we isolated and characterized the large and small EVs (lEVs, sEVs) released from SkM cells under basal conditions and in response to TNF‐α, a well‐established inflammatory mediator elevated in both acute muscle injury and chronic inflammatory conditions such as type 2 diabetes. We then evaluated the regenerative roles of these EV subtypes in vivo using a mouse model of cardiotoxin‐induced muscle injury, with a specific focus on their bioactive sphingolipid content. Using transmission, scanning or cryo‐electron microscopy, lipidomic profiling and an adenoviral construct to express labelled CD63 in myotubes, we demonstrated that SkM cells release both sEVs and lEVs primarily from the plasma membrane. Notably, sEVs were generated from specialized membrane folds enriched in the EV markers ALIX (ALG‐2 interacting protein X) and TSG101, as well as lipid raft‐associated lipids. During regeneration, sEVs promoted M1 macrophage polarization and migration and muscle stem cell (MuSC) differentiation, thereby accelerating muscle repair. In contrast, lEVs inhibited and promoted MuSC proliferation and impaired the transition from the pro‐inflammatory to the anti‐inflammatory response, an essential step for promoting MuSC differentiation. Treatment of isolated muscle fibres with SkM‐EVs revealed that the distinct effects of sEVs and lEVs on MuSC behaviour and macrophage phenotype could be largely explained by differences in their lipid composition, particularly the ratio of sphingosine‐1‐phosphate (S1P) subspecies. However, TNF‐α exposure altered these ratios in sEVs and impaired their regenerative functions on MuSC and their effect on macrophage migration and polarization. These results demonstrate for the first time the importance of the sphingolipid content of EVs released by skeletal muscle in their regenerative function within muscle tissue, largely explained by their role as carriers of different subspecies of sphingosine‐1‐phosphate. This suggests that modulating the sphingolipid composition of EVs could be a viable strategy to enhance the regenerative potential of muscle tissue in addition to therapeutic interventions.
Small extracellular vesicles called exosomes affect a variety of autocrine and paracrine cellular phenotypes, including cellular migration, immune activation, and neuronal function. Understanding the function of exosomes requires a variety of tools, including live cell imaging. We previously constructed a live-cell reporter, pHluorin-CD63, that allows dynamic subcellular monitoring of exosome secretion in migrating and spreading cells. However, there were some caveats to its use, including dim fluorescence and the inability to make cell lines that stably express the protein. By incorporating a stabilizing mutation in the pHluorin moiety, M153R, pHluorin-CD63 now exhibits higher and stable expression in cells and superior monitoring of exosome secretion. Using this improved construct, we demonstrate visualization of secreted exosomes in 3D culture and in vivo and identify a role for exosomes in promoting leader-follower behavior in 2D and 3D migration. By incorporating a further non-pH-sensitive red fluorescent tag, this reporter allows visualization of the exosome lifecycle, including multivesicular body (MVB) trafficking, MVB fusion, exosome uptake and endosome acidification. This new reporter will be a useful tool for understanding both autocrine and paracrine roles of exosomes.
Small extracellular vesicles (sEVs) in human serum carry diverse biomarkers and hold great potential for diagnostic and therapeutic applications. However, their isolation is challenging due to the presence of highly abundant serum proteins, particularly lipoproteins that closely resemble the sEVs in size and density. Existing lipoprotein removal methods cannot effectively remove all types of lipoproteins and may lead to potential contamination. Herein, we developed a lipoprotein‐depleting biomimetic core–shell liposome nanoparticle system composed of Fe 3 O 4 @SiO 2 cores coated with liposome bilayers (SL‐NPs). These lipoprotein‐mimicking nanoparticles exhibit efficient binding to lipoproteins that enable the selective removal of lipoproteins by low‐speed centrifugation while preserving sEVs. When applied as a complementary treatment step, this NP depletion strategy further enhances the purity of sEVs isolated from human serum or human plasma using ultracentrifugation or chemical precipitation methods. Nanoparticle tracking analysis, Western blot, ELISA, and proteomics analysis confirm the depletion of multiple classes of lipoproteins and the improvement of sEV purity after this additional nanoparticle depletion step. This strategy offers a simple, rapid, and effective approach to improve downstream biomarker analysis and applications of blood sEVs.